<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> DNA (mtDNA) content is essential for maintaining <z:mpath ids='MPATH_458'>normal</z:mpath> <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function, and the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function is critical for the production and the release of insulin in Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="?"><plain>We investigated whether peripheral blood mtDNA content was reduced in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and what were the major factors </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The mtDNA content of peripheral blood in a sample of 147 Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 170 <z:mpath ids='MPATH_458'>normal</z:mpath> Chinese subjects was determined by amplification of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> gene CYT-B and normalized by a nuclear DNA β-<z:chebi fb="0" ids="5386">globin</z:chebi> gene </plain></SENT>
<SENT sid="3" pm="."><plain>Fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA(1c) , fasting plasma insulin and <z:chebi fb="23" ids="18059">lipid</z:chebi> profile (<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, total cholesterol, <z:chebi fb="0" ids="17855">triglyceride</z:chebi>) were analysed with commercial kits on an automatic analyser </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> group, the mean HbA(1c) was 62 mmol/mol (7.8%) </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, BMI, systolic blood pressure, diastolic blood pressure, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, <z:chebi fb="0" ids="17855">triglyceride</z:chebi>, fasting plasma insulin and homeostasis model assessment for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> were significantly higher in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> group than that in control group </plain></SENT>
<SENT sid="6" pm="."><plain>Peripheral blood mtDNA content was 24% lower than that in the controls (1.4 ± 0.5 vs. 1.8 ± 0.7, P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>The mtDNA content was negatively correlated with BMI, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, fasting plasma insulin, homeostasis model assessment for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (P &lt; 0.01), and age, <z:chebi fb="0" ids="17855">triglyceride</z:chebi> and <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> levels (P &lt; 0.05); while positively correlated with <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> level (P &lt; 0.05) in both groups </plain></SENT>
<SENT sid="8" pm="."><plain>Stepwise regression analysis indicated that HbA(1c), fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:hpo ids='HP_0011007'>age of onset</z:hpo> were the major factors affecting the mtDNA content in the Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> group; however, BMI was the only variable associated with lower mtDNA content in control group </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our results demonstrate that lower peripheral blood mtDNA content is associated with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in Chinese individuals, and HbA(1c), fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:hpo ids='HP_0011007'>age of onset</z:hpo> are the major factors affecting the mtDNA content </plain></SENT>
</text></document>